Thomas Loudovaris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Thomas Loudovaris has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Helen E. Thomas
Immunology and Diabetes Unit, St Vincent’s Institute, Fitzroy, VIC, Australia
2 shared publications - Adrian Miller
Jirrbal Aboriginal Corporation, Ravenshoe, QLD 4888, Australia
1 shared publication Alice C.H. Chen
1 shared publication- Allen C. Cheng
Monash University
1 shared publication - Andrea T. Nguyen
Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia
1 shared publication - Andrew G. Brooks
Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3010, Australia
1 shared publication
Latest Publications
- Open Access
- 7 June 2021
- Published by MDPI AG in Metabolites
- Vol. 11 (6) , 363
Machine Learning Algorithms, Applied to Intact Islets of Langerhans, Demonstrate Significantly Enhanced Insulin Staining at the Capillary Interface of Human Pancreatic β Cells
Pancreatic β cells secrete the hormone insulin into the bloodstream and are critical in the control of blood glucose concentrations. β cells are clustered in the micro-organs of the islets of Langerhans, which have a rich capillary network. Recent work has highlighted the intimate spatial connections between β cells and these capillaries, which lead to the targeting of insulin secretion to the region where the β cells contact the capillary basement membrane. In addition, β cells orientate with respect to the capillary contact point and many proteins are differentially distributed at the capillary interface compared with the rest of the cell. Here, we set out to develop an automated image analysis approach to identify individual β cells within intact islets and to determine if the distribution of insulin across the cells was polarised. Our results show that a U-Net machine learning algorithm correctly identified β cells and their orientation with respect to the capillaries. Using this information, we then quantified insulin distribution across the β cells to show enrichment at the capillary interface. We conclude that machine learning is a useful analytical tool to interrogate large image datasets and analyse sub-cellular organisation.
- 7 June 2021
- Published by MDPI AG in Metabolites
- Vol. 11 (6) , 363
Open AccessMachine Learning Algorithms, Applied to Intact Islets of Langerhans, Demonstrate Significantly Enhanced Insulin Staining at the Capillary Interface of Human Pancreatic β Cells
Pancreatic β cells secrete the hormone insulin into the bloodstream and are critical in the control of blood glucose concentrations. β cells are clustered in the micro-organs of the islets of Langerhans, which have a rich capillary network. Recent work has highlighted the intimate spatial connections between β cells and these capillaries, which lead to the targeting of insulin secretion to the region where the β cells contact the capillary basement membrane. In addition, β cells orientate with respect to the capillary contact point and many proteins are differentially distributed at the capillary interface compared with the rest of the cell. Here, we set out to develop an automated image analysis approach to identify individual β cells within intact islets and to determine if the distribution of insulin across the cells was polarised. Our results show that a U-Net machine learning algorithm correctly identified β cells and their orientation with respect to the capillaries. Using this information, we then quantified insulin distribution across the β cells to show enrichment at the capillary interface. We conclude that machine learning is a useful analytical tool to interrogate large image datasets and analyse sub-cellular organisation.
- Open Access
CD8 + T-cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph
Indigenous people worldwide are at high-risk of developing severe influenza disease. HLA-A*24:02 allele, highly prevalent in Indigenous populations, is associated with influenza-induced mortality, although the basis for this association is unclear. We defined CD8 + T-cell immune landscapes against influenza A (IAV) and B (IBV) viruses in HLA-A*24:02-expressing Indigenous and non-Indigenous individuals, human tissues, influenza-infected patients and HLA-A*24:02-transgenic mice. We identified immunodominant protective CD8 + T-cell epitopes, one towards IAV and six towards IBV, with A24/PB2 550-558 -specific CD8 + T-cells cells being cross-reactive between IAV and IBV. Memory CD8 + T-cells towards these specificities were present in blood (CD27 + CD45RA - phenotype) and tissues (CD103 + CD69 + phenotype) of healthy subjects, and effector CD27 - CD45RA - PD-1 + CD38 + CD8 + T-cells in IAV/IBV patients. Our data present the first evidence of influenza-specific CD8 + T-cell responses in Indigenous Australians, and advocate for T-cell-mediated vaccines that target and boost the breadth of IAV/IBV-specific CD8 + T-cells to protect high-risk HLA-A*24:02-expressing Indigenous and non-Indigenous populations from severe influenza disease. One Sentence Summary: Influenza-specific CD8 + T-cell specificities restricted by HLA-A*24:02.
Open AccessCD8 + T-cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph
Indigenous people worldwide are at high-risk of developing severe influenza disease. HLA-A*24:02 allele, highly prevalent in Indigenous populations, is associated with influenza-induced mortality, although the basis for this association is unclear. We defined CD8 + T-cell immune landscapes against influenza A (IAV) and B (IBV) viruses in HLA-A*24:02-expressing Indigenous and non-Indigenous individuals, human tissues, influenza-infected patients and HLA-A*24:02-transgenic mice. We identified immunodominant protective CD8 + T-cell epitopes, one towards IAV and six towards IBV, with A24/PB2 550-558 -specific CD8 + T-cells cells being cross-reactive between IAV and IBV. Memory CD8 + T-cells towards these specificities were present in blood (CD27 + CD45RA - phenotype) and tissues (CD103 + CD69 + phenotype) of healthy subjects, and effector CD27 - CD45RA - PD-1 + CD38 + CD8 + T-cells in IAV/IBV patients. Our data present the first evidence of influenza-specific CD8 + T-cell responses in Indigenous Australians, and advocate for T-cell-mediated vaccines that target and boost the breadth of IAV/IBV-specific CD8 + T-cells to protect high-risk HLA-A*24:02-expressing Indigenous and non-Indigenous populations from severe influenza disease. One Sentence Summary: Influenza-specific CD8 + T-cell specificities restricted by HLA-A*24:02.
- Open Access
A Combinatorial Protein Microarray for Probing Materials Interaction with Pancreatic Islet Cell Populations
Pancreatic islet transplantation has become a recognized therapy for insulin-dependent diabetes mellitus. During isolation from pancreatic tissue, the islet microenvironment is disrupted. The extracellular matrix (ECM) within this space not only provides structural support, but also actively signals to regulate islet survival and function. In addition, the ECM is responsible for growth factor presentation and sequestration. By designing biomaterials that recapture elements of the native islet environment, losses in islet function and number can potentially be reduced. Cell microarrays are a high throughput screening tool able to recreate a multitude of cellular niches on a single chip. Here, we present a screening methodology for identifying components that might promote islet survival. Automated fluorescence microscopy is used to rapidly identify islet derived cell interaction with ECM proteins and immobilized growth factors printed on arrays. MIN6 mouse insulinoma cells, mouse islets and, finally, human islets are progressively screened. We demonstrate the capability of the platform to identify ECM and growth factor protein candidates that support islet viability and function and reveal synergies in cell response.
Open AccessA Combinatorial Protein Microarray for Probing Materials Interaction with Pancreatic Islet Cell Populations
Pancreatic islet transplantation has become a recognized therapy for insulin-dependent diabetes mellitus. During isolation from pancreatic tissue, the islet microenvironment is disrupted. The extracellular matrix (ECM) within this space not only provides structural support, but also actively signals to regulate islet survival and function. In addition, the ECM is responsible for growth factor presentation and sequestration. By designing biomaterials that recapture elements of the native islet environment, losses in islet function and number can potentially be reduced. Cell microarrays are a high throughput screening tool able to recreate a multitude of cellular niches on a single chip. Here, we present a screening methodology for identifying components that might promote islet survival. Automated fluorescence microscopy is used to rapidly identify islet derived cell interaction with ECM proteins and immobilized growth factors printed on arrays. MIN6 mouse insulinoma cells, mouse islets and, finally, human islets are progressively screened. We demonstrate the capability of the platform to identify ECM and growth factor protein candidates that support islet viability and function and reveal synergies in cell response.
- 1 December 2015
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 110 (3) , 291-300
Localization of dipeptidyl peptidase-4 (CD26) to human pancreatic ducts and islet alpha cells
- 1 December 2015
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 110 (3) , 291-300
Localization of dipeptidyl peptidase-4 (CD26) to human pancreatic ducts and islet alpha cells
- 1 December 2014
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 8, 65-66
Modulation of pancreatic islet oxidative and ER stress with IL-22 to ameliorate metabolic syndrome in obesity
- 1 December 2014
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 8, 65-66
Modulation of pancreatic islet oxidative and ER stress with IL-22 to ameliorate metabolic syndrome in obesity